Qing Yao

Most-cited papers

1. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains

   Shan Li, Li Zhang, Qing Yao, Lin Li +8 more

   2013Nature261 citations

   Semantic Scholar

   Save

2. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.

   Qing Yao, Hui Xu, Qian-Qian Zhang, Hui Zhou +1 more

   2009Biochemical and Biophysical Research Communications - BBRC215 citations

   Semantic Scholar

   Save

3. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.

   Ashish R. Kumar, W. Hudson, Wei-Li Chen, R. Nishiuchi +2 more

   2004Blood143 citations Open access

   Semantic Scholar

   Save

4. FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.

   Qing Yao, R. Nishiuchi, Quanzhi Li, Ashish R. Kumar +2 more

   2003Clinical Cancer Research120 citations

   Semantic Scholar

   Save

5. A role for MEIS1 in MLL-fusion gene leukemia.

   Ashish R. Kumar, Quanzhi Li, W. Hudson, Wei-Li Chen +6 more

   2009Blood111 citations Open access

   Semantic Scholar

   Save

6. MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.

   Qian-Qian Zhang, Hui Xu, Mian-bo Huang, Liming Ma +4 more

   2012Neuro-Oncology96 citations Open access

   Semantic Scholar

   Save

7. Synergism between Etoposide and 17-AAG in Leukemia Cells: Critical Roles for Hsp90, FLT3, Topoisomerase II, Chk1, and Rad51

   Qing Yao, B. Weigel, J. Kersey

   2007Clinical Cancer Research63 citations Open access

   Semantic Scholar

   Save

8. Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.

   Jennifer J. Johnson, Wei-Li Chen, W. Hudson, Qing Yao +3 more

   2003Blood53 citations

   Semantic Scholar

   Save

9. Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway

   Qing Yao, Ritsuo Nishiuchi, Tadaichi Kitamura, J. Kersey

   2005Leukemia48 citations Open access

   Semantic Scholar

   Save

10. t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL

    Ashish R. Kumar, Qing Yao, Quanzhi Li, T. Sam +1 more

    2010Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis29 citations Open access

    Semantic Scholar

    Save

11. Egr2 enhances insulin resistance via JAK2/STAT3/SOCS-1 pathway in HepG2 cells treated with palmitate.

    Lin Lu, Xinhua Ye, Qing Yao, Aijiao Lu +6 more

    2017General and Comparative Endocrinology26 citations

    Semantic Scholar

    Save

12. Analysis of Differentially Expressed Genes in Endothelial Cells Following Tumor Cell Adhesion, and the Role of PRKAA2 and miR-124-3p

    Yan Pan, Marhaba Abdureyim, Qing Yao, Xuejun Li

    2021Frontiers in Cell and Developmental Biology7 citations Open access

    Semantic Scholar

    Save

13. Authors' comments: t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL.

    Ashish R. Kumar, Qing Yao, Quanzhi Li, T. Sam +1 more

    2011Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations

    Semantic Scholar

    Save

14. The Hsp90 Inhibitor, 17-AAG, and Topoisomerase ll Inhibitor, Etoposide, Synergistically Inhibit Leukemias with FLT3 Mutations through Inhibition of DNA Repair Proteins, Chk1 and Rad51.

    Qing Yao, B. Weigel, J. Kersey

    20050 citations

    Semantic Scholar

    Save

15. The Hsp90 Inhibitor 17-AAG and FLT3 Kinase Inhibitor GTP14564 Synergistically Inhibit MLL Fusion Gene Leukemias with FLT3 Mutations.

    Qing Yao, R. Nishiuchi, T. Kitamura, J. Kersey

    20040 citations

    Semantic Scholar

    Save